Tolerogenic donor-derived dendritic cells risk sensitization in vivo owing to processing and presentation by recipient APCs

Journal of Immunology

Volumn 190, Issue 9, 2013, Pages 4848-4860

  Smyth, Lesley A ^a   Ratnasothy, Kulachelvy ^a   Moreau, Aurelie ^a   Alcock, Sally ^a   Sagoo, Pervinder ^a   Meader, Lucy ^a   Tanriver, Yakup ^a   Buckland, Matthew ^a   Lechler, Robert ^a,b   Lombardi, Giovanna ^a,b  

^a GUY S HOSPITAL   (United Kingdom)

^b Camden and Islington National Health Service Foundation Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; DENDRITIC CELL VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; OKT 8; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ADVERSE OUTCOME; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CARDIAC GRAFT REJECTION; CD8+ T LYMPHOCYTE; CELL EXPANSION; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE EXACERBATION; DRUG SENSITIZATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN GRAFT REJECTION; T LYMPHOCYTE ACTIVATION; VACCINE FAILURE;

ANIMALS; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNE TOLERANCE; ISOANTIGENS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL; SKIN TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION;

EID: 84876786196     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200870     Document Type: Article

References (71)

1. Lechler, R. I., and A. J. T. George. 2006. Transplantation and rejection. In Immunology, 7th Ed., D. Male, J. Brostoff, D. B. Roth, and I. Roitt, eds. Mosby Elsevier, Philadelphia, p. 383-399.
2. Long, E., and K. J. Wood. 2009. Regulatory T cells in transplantation: transferring mouse studies to the clinic. Transplantation 88: 1050-1056.
3. Feng, G., T. Chan, K. J. Wood, and A. Bushell. 2009. Donor reactive regulatory T cells. Curr. Opin. Organ Transplant. 14: 432-438.
4. Silk, K. M., and P. J. Fairchild. 2009. Harnessing dendritic cells for the induction of transplantation tolerance. Curr. Opin. Organ Transplant. 14: 344-350.
5. Hackstein, H., and A. W. Thomson. 2004. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4: 24-34. (Pubitemid 38084129)
6. Morelli, A. E., and A. W. Thomson. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7: 610-621. (Pubitemid 47123548)
7. Griffin, M. D., W. H. Lutz, V. A. Phan, L. A. Bachman, D. J. McKean, and R. Kumar. 2000. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophys. Res. Commun. 270: 701-708. (Pubitemid 30444768)
8. Dong, X., T. Craig, N. Xing, L. A. Bachman, C. V. Paya, F. Weih, D. J. McKean, R. Kumar, and M. D. Griffin. 2003. Direct transcriptional regulation of RelB by 1alpha, 25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. J. Biol. Chem. 278: 49378-49385.
9. Rea, D., C. van Kooten, K. E. van Meijgaarden, T. H. Ottenhoff, C. J. Melief, and R. Offringa. 2000. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 95: 3162-3167. (Pubitemid 30321168)
10. Roelen, D. L., D. H. Schuurhuis, D. E. M. van den Boogaardt, K. Koekkoek, P. P. M. C. van Miert, J. J. van Schip, S. Laban, D. Rea, C. J. M. Melief, R. Offringa, et al. 2003. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 76: 1608-1615. (Pubitemid 37549835)
11. Adorini, L., G. Penna, N. Giarratana, and M. Uskokovic. 2003. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J. Cell. Biochem. 88: 227-233. (Pubitemid 36119891)
12. Matyszak, M. K., S. Citterio, M. Rescigno, and P. Ricciardi-Castagnoli. 2000. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur. J. Immunol. 30: 1233-1242. (Pubitemid 30216241)
13. Xing, N., M. L. L Maldonado, L. A. Bachman, D. J. McKean, R. Kumar, and M. D. Griffin. 2002. Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. Biochem. Biophys. Res. Commun. 297: 645-652.
14. Woltman, A. M., S. W. van der Kooij, J. W. de Fijter, and C. van Kooten. 2006. Maturation-resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA+ and CD45RO+ T-cell populations. Am. J. Transplant. 6: 2580-2591. (Pubitemid 44571678)
15. Canning, M. O., K. Grotenhuis, H. de Wit, C. Ruwhof, and H. A. Drexhage. 2001. 1-alpha, 25-Dihydroxyvitamin D3 (1, 25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endo-crinol. 145: 351-357. (Pubitemid 32825669)
16. Rozkova, D., R. Horvath, J. Bartunkova, and R. Spisek. 2006. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin. Immunol. 120: 260-271. (Pubitemid 44175897)
17. Piemonti, L., P. Monti, M. Sironi, P. Fraticelli, B. E. Leone, E. Dal Cin, P. Allavena, and V. Di Carlo. 2000. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 164: 4443-4451. (Pubitemid 30238038)
18. Penna, G., and L. Adorini. 2000. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164: 2405-2411. (Pubitemid 30115468)
19. Penna, G., S. Amuchastegui, N. Giarratana, K. C. Daniel, M. Vulcano, S. Sozzani, and L. Adorini. 2007. 1, 25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 178: 145-153. (Pubitemid 46033595)
20. Buckland, M., C. B. Jago, H. Fazekasova, K. Scott, P. H. Tan, A. J. George, R. Lechler, and G. Lombardi. 2006. Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells. Am. J. Transplant. 6: 2046-2059. (Pubitemid 44199539)
21. Pedersen, A. E., M. Gad, M. R. Walter, and M. H. Claesson. 2004. Induction of regulatory dendritic cells by dexamethasone and 1alpha, 25-dihydroxyvitamin D (3). Immunol. Lett. 91: 63-69. (Pubitemid 38147747)
22. Emmer, P. M., J. van der Vlag, G. J. Adema, and L. B. Hilbrands. 2006. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation 81: 1451-1459. (Pubitemid 43852991)
23. Divito, S. J., Z. Wang, W. J. Shufesky, Q. Liu, O. A. Tkacheva, A. Montecalvo, G. Erdos, A. T. Larregina, and A. E. Morelli. 2010. Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation. Blood 116: 2694-2705.
24. Pedersen, A. E., E. G. Schmidt, M. Gad, S. S. Poulsen, and M. H. Claesson. 2009. Dexamethasone/1alpha-25-dihydroxyvitamin D3-treated dendritic cells suppress colitis in the SCID T-cell transfer model. Immunology 127: 354-364.
25. Bonham, C. A., L. Peng, X. Liang, Z. Chen, L. Wang, L. Ma, H. Hackstein, P. D. Robbins, A. W. Thomson, J. J. Fung, et al. 2002. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J. Immunol. 169: 3382-3391. (Pubitemid 35013188)
26. DePaz, H. A., O. O. Oluwole, A. O. Adeyeri, P. Witkowski, M. X. Jin, M. A. Hardy, and S. F. Oluwole. 2003. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival. Transplantation 75: 521-528. (Pubitemid 36241150)
27. Lan, Y. Y., Z. Wang, G. Raimondi, W. Wu, B. L. Colvin, A. de Creus, and A. W. Thomson. 2006. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allo-graft survival in combination with CTLA4-Ig. J. Immunol. 177: 5868-5877. (Pubitemid 44628800)
28. Zhang, X., M. Li, D. Lian, X. Zheng, Z. X. Zhang, T. E. Ichim, X. Xia, X. Huang, C. Vladau, M. Suzuki, et al. 2008. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clin. Immunol. 127: 313-321.
29. Xu, D. L., Y. Liu, J. M. Tan, B. Li, C. P. Zhong, X. H. Zhang, C. Q. Wu, and X. D. Tang. 2004. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells. Scand. J. Immunol. 59: 536-544. (Pubitemid 38789222)
30. Turnquist, H. R., G. Raimondi, A. F. Zahorchak, R. T. Fischer, Z. Wang, and A. W. Thomson. 2007. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J. Immunol. 178: 7018-7031. (Pubitemid 46847428)
31. Pearson, T. C., D. Z. Alexander, R. Hendrix, E. T. Elwood, P. S. Linsley, K. J. Winn, and C. P. Larsen. 1996. CTLA4-Ig plus bone marrow induces longterm allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism. Transplantation 61: 997-1004.
32. Wang, Z., A. E. Morelli, H. Hackstein, K. Kaneko, and A. W. Thomson. 2003. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb. Transplantation 76: 562-571. (Pubitemid 37013264)
33. Mirenda, V., I. Berton, J. Read, T. Cook, J. Smith, A. Dorling, and R. I. Lechler. 2004. Modified dendritic cells coexpressing self and allogeneic major histo-compatibility complex molecules: an efficient way to induce indirect pathway regulation. J. Am. Soc. Nephrol. 15: 987-997. (Pubitemid 38375317)
34. Yamano, T., S. Watanabe, H. Hasegawa, T. Suzuki, R. Abe, H. Tahara, T. Nitta, N. Ishimaru, J. Sprent, and H. Kishimoto. 2011. Ex vivo-expanded DCs induce donor-specific central and peripheral tolerance and prolong the acceptance of donor skin grafts. Blood 117: 2640-2648.
35. Fonteneau, J. F., D. G. Kavanagh, M. Lirvall, C. Sanders, T. L. Cover, N. Bhardwaj, and M. Larsson. 2003. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 102: 4448-4455. (Pubitemid 37494109)
36. Inaba, K., S. Turley, F. Yamaide, T. Iyoda, K. Mahnke, M. Inaba, M. Pack, M. Subklewe, B. Sauter, D. Sheff, et al. 1998. Efficient presentation of phago-cytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188: 2163-2173. (Pubitemid 28562532)
37. Knudsen, S., A. Schardt, T. Buhl, L. Boeckmann, M. P. Schön, C. Neumann, and H. A. Haenssle. 2010. Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells. Exp. Dermatol. 19: 108-116.
38. de Kort, H., C. Crul, A. M. van der Wal, N. Schlagwein, A. M. Stax, J. A. Bruijn, C. van Kooten, and E. de Heer. 2012. Accelerated antibody-mediated graft loss of rodent pancreatic islets after pretreatment with dexamethasone-treated immature donor dendritic cells. Transplantation 94: 903-910.
39. Hildner, K., B. T. Edelson, W. E. Purtha, M. Diamond, H. Matsushita, M. Kohyama, B. Calderon, B. U. Schraml, E. R. Unanue, M. S. Diamond, et al. 2008. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322: 1097-1100.
40. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
41. Billingham, R. E., L. Brent, and P. B. Medawar. 1953. Actively acquired tolerance of foreign cells. Nature 172: 603-606.
42. Tsang, J. Y., Y. Tanriver, S. Jiang, S. A. Xue, K. Ratnasothy, D. Chen, H. J. Stauss, R. P. Bucy, G. Lombardi, and R. Lechler. 2008. Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J. Clin. Invest. 118: 3619-3628.
43. Tsang, J. Y., Y. Tanriver, S. Jiang, E. Leung, K. Ratnasothy, G. Lombardi, and R. Lechler. 2009. Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression. Transpl. Immunol. 21: 203-209.
44. Hackstein, H., T. Taner, A. J. Logar, and A. W. Thomson. 2002. Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells. Blood 100: 1084-1087. (Pubitemid 34832646)
45. Hackstein, H., A. E. Morelli, A. T. Larregina, R. W. Ganster, G. D. Papworth, A. J. Logar, S. C. Watkins, L. D. Falo, and A. W. Thomson. 2001. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J. Immunol. 166: 7053-7062. (Pubitemid 32525574)
46. Creusot, R. J., S. S. Yaghoubi, P. Chang, J. Chia, C. H. Contag, S. S. Gambhir, and C. G. Fathman. 2009. Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. Blood 113: 6638-6647.
47. Anderson, A. E., D. J. Swan, B. L. Sayers, R. A. Harry, A. M. Patterson, A. von Delwig, J. H. Robinson, J. D. Isaacs, and C. M. U. Hilkens. 2009. LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J. Leukoc. Biol. 85: 243-250.
48. Lu, L., W. Li, F. Fu, F. G. Chambers, S. Qian, J. J. Fung, and A. W. Thomson. 1997. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64: 1808-1815. (Pubitemid 28041722)
49. Pêche, H., B. Trinité, B. Martinet, and M. C. Cuturi. 2005. Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am. J. Transplant. 5: 255-267. (Pubitemid 40179512)
50. Smyth, L. A., C. Hervouet, T. Hayday, P. D. Becker, R. Ellis, R. I. Lechler, G. Lombardi, and L. S. Klavinskis. 2012. Acquisition of MHC:peptide complexes by dendritic cells contributes to the generation of antiviral CD8+ T cell immunity in vivo. J. Immunol. 189: 2274-2282.
51. Fuertes Marraco, S. A., C. L. Scott, P. Bouillet, A. Ives, S. Masina, D. Vremec, E. S. Jansen, L. A. O'Reilly, P. Schneider, N. Fasel, et al. 2011. Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo. PLoS ONE 6: e20189.
52. Wilson, N. S., G. M. Behrens, R. J. Lundie, C. M. Smith, J. Waithman, L. Young, S. P. Forehan, A. Mount, R. J. Steptoe, K. D. Shortman, et al. 2006. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7: 165-172. (Pubitemid 43135882)
53. Chamorro, S., J. J. García-Vallejo, W. W. J. Unger, R. J. Fernandes, S. C. M. Bruijns, S. Laban, B. O. Roep, B. A. 't Hart, and Y. van Kooyk. 2009. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J. Immunol. 183: 2984-2994.
54. Gordon, R. D., E. Simpson, and L. E. Samelson. 1975. In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice. J. Exp. Med. 142: 1108-1120.
55. Edinger, M., P. Hoffmann, J. Ermann, K. Drago, C. G. Fathman, S. Strober, and R. S. Negrin. 2003. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 9: 1144-1150. (Pubitemid 37173698)
56. Bevan, M. J. 1975. Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier. Nature 256: 419-421.
57. Bevan, M. J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143: 1283-1288.
58. Bevan, M. J. 1976. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117: 2233-2238. (Pubitemid 8009022)
59. Kuffová, L., M. Netuková, L. Duncan, A. Porter, B. Stockinger, and J. V. Forrester. 2008. Cross presentation of antigen on MHC class II via the draining lymph node after corneal transplantation in mice. J. Immunol. 180: 1353-1361.
60. Liu, K., T. Iyoda, M. Saternus, Y. Kimura, K. Inaba, and R. M. Steinman. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196: 1091-1097. (Pubitemid 35231767)
61. Williams, M. A., T. M. Onami, A. B. Adams, M. M. Durham, T. C. Pearson, R. Ahmed, and C. P. Larsen. 2002. Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen. J. Immunol. 169: 5387-5391. (Pubitemid 35291632)
62. Yu, G., X. Xu, M. D. Vu, E. D. Kilpatrick, and X. C. Li. 2006. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J. Exp. Med. 203: 1851-1858. (Pubitemid 44188459)
63. Giannoukakis, N., B. Phillips, D. Finegold, J. Harnaha, and M. Trucco. 2011. Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 34: 2026-2032.
64. Isaacs, J. D., and G. M. Bell. 2011. Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA). ClinicalTrials.gov.
65. Finkelman, F. D., A. Lees, R. Birnbaum, W. C. Gause, and S. C. Morris. 1996. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157: 1406-1414. (Pubitemid 126449077)
66. Bonifaz, L., D. Bonnyay, K. Mahnke, M. Rivera, M. C. Nussenzweig, and R. M. Steinman. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196: 1627-1638. (Pubitemid 36026474)
67. Bruder, D., A. M. Westendorf, W. Hansen, S. Prettin, A. D. Gruber, Y. Qian, H. von Boehmer, K. Mahnke, and J. Buer. 2005. On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 54: 3395-3401. (Pubitemid 43334328)
68. Yamazaki, S., D. Dudziak, G. F. Heidkamp, C. Fiorese, A. J. Bonito, K. Inaba, M. C. Nussenzweig, and R. M. Steinman. 2008. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 181: 6923-6933.
69. Dudziak, D., A. O. Kamphorst, G. F. Heidkamp, V. R. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, K. Liu, H. W. Lee, C. G. Park, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315: 107-111. (Pubitemid 46196991)
70. Mukhopadhaya, A., T. Hanafusa, I. Jarchum, Y. G. Chen, Y. Iwai, D. V. Serreze, R. M. Steinman, K. V. Tarbell, and T. P. DiLorenzo. 2008. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc. Natl. Acad. Sci. USA 105: 6374-6379. (Pubitemid 351758353)
71. Tanriver, Y., K. Ratnasothy, R. P. Bucy, G. Lombardi, and R. Lechler. 2010. Targeting MHC class I monomers to dendritic cells inhibits the indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term allograft survival. J. Immunol. 184: 1757-1764.